Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P08908 (
5-HT1A
)
5,574
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Quantitative autoradiography was used to evaluate the time course and reversibility of corticosterone (CORT)-induced decreases in binding at
5-HT1A
receptors in the dorsal hippocampus, cortex and septum of the male rat. Continuous exposure to high levels of CORT decreased binding of [3H]8-hydroxy-2-(di-n-propylamino)tetralin at
5-HT1A
receptors in the dentate gyrus and in the oriens and lacunosum moleculare layers of CA4 after 16 to 48 h. CORT-induced decreases in binding were also observed in the dorsal lateral septum after 2-4 days, and in the intermediate lateral septum after 4-8 days of exposure to high levels of CORT. When CORT pellets that had remained in rats for 8 days were removed 3 weeks prior to sacrifice, binding at
5-HT1A
receptors increased in comparison to control values in the oriens and lacunosum moleculare layers of CA2, and in layers 4-6 of the parietal/temporal cortex. These increases in binding were associated with very low serum CORT levels, and resembled increases previously observed in those areas in
ADX
rats. Although removal of CORT reversed the decreases in binding in the septum, no significant increases above control values were observed. Thus, there appear to be differences in the degree of sensitivity in the various brain regions to low and high levels of circulating adrenal steroids.
...
PMID:Quantitative autoradiographic analyses of the time course and reversibility of corticosterone-induced decreases in binding at 5-HT1A receptors in rat forebrain. 136 98
Quantitative autoradiography was used to evaluate the effects of adrenalectomy (
ADX
) and corticosterone (CORT) on binding at
5-HT1A
and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat.
ADX
increased binding of [3H]8-hydroxy-2-(di-n-propylamino)tetralin at
5-HT1A
receptors in the oriens and lacunosum moleculare layers of CA2 and CA3, in the lacunosum moleculare layer of CA4 region, and in the dentate gyrus. In restraint-stressed
ADX
rats, binding was increased only in the oriens and lacunosum moleculare layers of CA2. Restoration of baseline levels of CORT reversed the effects of
ADX
on
5-HT1A
receptors in the hippocampus, while high levels of CORT decreased binding at
5-HT1A
receptors in the dentate gyrus. No treatment affected binding at
5-HT1A
receptors in the CA1 region of the hippocampus or in the cortex.
ADX
increased binding of [125I]iodocyanopindolol at 5-HT1B receptors in the infrapyramidal dentate, but this effect was not observed in
ADX
rats that were restrained. CORT treatment in both
ADX
and SHAM (adrenally intact) rats resulted in binding at 5-HT1B receptors that was lower than that in untreated
ADX
and SHAM rats in the infrapyramidal dentate, and lower than that in
ADX
rats in the suprapyramidal dentate and CA4. In
ADX
and SHAM rats, CORT also reduced binding at 5-HT1B receptors in area 2 of the cortex. It is suggested that decreases in binding at
5-HT1A
and 5-HT1B/1D receptors resulting from chronic exposure to high levels of CORT may also occur in animals that fail to adapt to chronic severe stress. Such changes in binding may play important roles in the etiology of depression.
...
PMID:Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT1A and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat. 153 16
Serotonin and dexamethasone act as differentiating agents during development. Reducing circulating adrenal steroids or central 5-HT levels via adrenalectomy (
ADX
) or the tryptophan hydroxylase inhibitor, para-chlorophenylalanine (PCPA), respectively, has been shown to have de-differentiating effects in the adult brain. Morphometric analysis of 5-HT, S100 beta, MAP-2 and synaptophysin immunoreactivity (IR) was used to follow the molecular plasticity of several brain regions after lesioning of 5-HT nerve terminals by para-chloroamphetamine (PCA; 2 x 10 mg/kg s.c.), a serotonin neurotoxin. Two weeks after PCA treatment we observed reductions of 5-HT, S100 beta, and MAP-2 IR in parietal and temporal cortex, temporal pole, hippocampus and hypothalamus. The reductions in MAP-2 and synaptophysin-IR were reversed by 3 days of treatment with dexamethasone (10 mg/l drinking water) or ipsapirone, a
5-HT1A
agonist (1 mg/kg s.c.). The loss of S100-IR was reversed only by the
5-HT1A
agonist. These results indicate that both dexamethasone and serotonin have effects on adult neuronal plasticity but may work via different mechanisms. The implications of these findings to the loss of synaptophysin and MAP-2 staining in Alzheimer's disease are discussed.
...
PMID:5-HT1A agonist and dexamethasone reversal of para-chloroamphetamine induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain. 755 42
Corticosterone (CT) treatment decreases the magnitude of the 5-hydroxytryptamine (5-HT)1A receptor-mediated hyperpolarization in rat CA1 hippocampal pyramidal neurons. In the present study, we examined the short- and long-term effects of CT on the functionally excitatory 5-HT4 receptor-mediated decrease in the amplitude of the slow afterhyperpolarization (sAHP) that follows a calcium spike and the concomitant decrease in sAHP half decay time. Rats were adrenalectomized (
ADX
) 2 weeks before the experiment. Data for concentration-response curves were obtained with sharp electrode current clamp recordings in the CA1 pyramidal cell layer of hippocampal slices. Significant changes were found in the 5-HT4 receptor-mediated decrease in sAHP amplitude. The Emax of the 5-HT4 response was significantly increased in cells from
ADX
rats when the superfusion medium contained 1 nM CT. Short-term administration of 100 nM CT did not alter the 5-HT4 response. Chronic treatment with low concentrations of CT decreased the Emax of the 5-HT4 response. Treatment with CT concentrations that mimic conditions of chronic stress decreased the Emax of the 5-HT4 response and shifted the EC50 to the right. Based on these results we conclude that the magnitude and the potency of the 5-HT4 receptor-mediated decrease in sAHP amplitude is altered by CT. Because the short- and long-term effects of CT treatment are not the same, the actions of CT are time and concentration dependent. CT modulation of the 5-HT4 response is different from its modulation of the
5-HT1A
response.
...
PMID:Modulation of the 5-hydroxytryptamine4 receptor-mediated response by short-term and long-term administration of corticosterone in rat CA1 hippocampal pyramidal neurons. 779 Oct 83
Differentiation leads to specific morphological and biochemical characteristics. We examined whether epigenetic factors (e.g., glucocorticoids) are required to maintain neuronal differentiation in the adult brain. In the midbrain, adrenalectomy (
ADX
) (1-2 wk) reduced the size of tryptophan hydroxylase (WH)-immunoreactive (IR) neurons.
ADX
rats exposed to short-term (24-72-h) dexamethasone (ST-DEX) in the drinking saline (10 mg/l) showed an increase in WH protein, somal area and dendritic size of WH-IR neurons. In the hippocampus,
ADX
for 2-3 mo (long-term; LT) reduced Nissl staining, calbindin (CBD)-IR and
5-HT1A
receptor mRNA in the granular cell layer, and the size of the molecular layer and its CBD-IR dendrites. Small vimentin (Vim)-IR glial cells emerged in the granular layer. ST-DEX after LT-
ADX
rapidly induced a recovery of
5-HT1A
mRNA, Nissl labeling and CBD-IR in the granule cell layer. In the molecular layer, there was an increase in the area and in the number of CBD-IR dendrites. Furthermore, the Vim-IR glial cells were enlarged in size and branching. The rate of cell proliferation was studied in these animals. Immunostaining with antibodies against proliferating cell nuclear antigen (PCNA) and use of bromouridine argue against enhanced neurogenesis after ST-DEX in LT-
ADX
. We propose that glucocorticoids induce and maintain differentiation of serotonergic and CBD-IR neurons in the midbrain-hippocampal axis. A neuronotrophic role for the glial
5-HT1A
receptor is suggested.
...
PMID:Dexamethasone reverses adrenalectomy-induced neuronal de-differentiation in midbrain raphe-hippocampus axis. 782 75
Previous studies have shown that adrenalectomy (
ADX
) increases the binding of 3H-DPAT to
5-HT1A
receptors in the hippocampus (HIP) and this effect is partially overcome by corticosterone (CORT) replacement. The present study investigated the time course of the effects of
ADX
with or without CORT replacement on serotonin (5-HT) pre- and postsynaptic systems in the HIP and dorsal raphe nucleus (DR) by quantitative autoradiography. In the HIP,
ADX
for 7, 10 or 14 days caused a significant increase in 3H-DPAT binding in the CA1 region (pyramidal layer), CA2,3 region (molecular and pyramidal layers) and in the dentate gyrus (molecular and granular layers) which returned to control levels when measurements were made 35 days post-
ADX
. A decrease in 3H-DPAT binding was observed 14 days after
ADX
in the DR but not in the median raphe nucleus (MR). Although replacement with CORT did not lead to a reversal in 3H-DPAT binding early time points, binding was restored to control levels 7-28 days after CORT replacement in all regions of the HIP. In the DR, CORT did not cause a reversal in 3H-DPAT binding at any of the time points examined. In contrast to the effects seen on the
5-HT1A
receptor subtype, no significant change was noted on the binding of 3H-CN-IMI to uptake sites for 5-HT in the HIP or DR after
ADX
or CORT replacement. The results of this study indicate that long-term alterations in the HPA axis lead to changes in the
5-HT1A
receptor system that are both region-specific and time-dependent.
...
PMID:Time course of the effects of adrenalectomy and corticosterone replacement on 5-HT1A receptors and 5-HT uptake sites in the hippocampus and dorsal raphe nucleus of the rat brain: an autoradiographic analysis. 786 63
We evaluated the effects of adrenalectomy (
ADX
) and replacement with glucocorticoid receptor agonists on serotonin (5-HT)
5-HT1A
and 5-HT2 receptor binding in rat brain.
5-HT1A
receptor binding was increased in the CA2-CA4 and the dentate gyrus of the hippocampus 1 week after
ADX
. This effect was prevented by the systemic administration of aldosterone (10 micrograms/microliters/h) but not by RU28362 (10 micrograms/microliters/h). No significant effect was observed on 5-HT2 receptor binding in rat cortex. The expression of 5-HT transporter mRNA was unchanged in the raphe nucleus as measured by in situ hybridization.
...
PMID:Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on 5-HT1A and 5-HT2 receptor binding and 5-HT transporter mRNA expression in rat brain. 792 18
Using in situ hybridization techniques, the expression of
5-HT1A
receptor mRNA was measured within the hippocampal formation after bilateral adrenalectomy (
ADX
). After 24 hr
ADX
,
5-HT1A
receptor mRNA expression was significantly increased in all hippocampal subfields in
ADX
animals relative to sham-operated controls (SHAM). The magnitude of the increase was most pronounced within CA2 (127%) and CA3/4 (94%)-subfields of dorsal hippocampus, intermediate in the dentate gyrus (73%), and least within CA1 (60%). Administration of exogenous corticosterone (CORT) at the time of
ADX
maintained the level of
5-HT1A
receptor mRNA expression within the range of SHAM animals. In vitro receptor autoradiographic analysis of
5-HT1A
receptors in adjacent sections from the same animals indicated a simultaneous increase in
5-HT1A
binding throughout the hippocampus in response to
ADX
.
5-HT1A
binding increased to a similar extent (approximately 30%) in CA subfields and dentate gyrus but remained within SHAM levels in CORT-replaced animals.
5-HT1A
receptor mRNA levels were also increased in hippocampal subregions of 1 week
ADX
animals relative to SHAM animals. Within both CA1 and CA2 subfields, the increments were approximately double those observed after 1 d
ADX
.
5-HT1A
receptor binding was increased in every hippocampal subfield to a similar extent as that observed after 1 d
ADX
. Increases in both
5-HT1A
receptor mRNA expression and
5-HT1A
receptor binding were preventable by administration of exogenous CORT at the time of
ADX
. Hippocampal 5-HT1C receptor mRNA and D1 receptor mRNA expression were not significantly altered by either acute or chronic
ADX
treatment. These data indicate that adrenal steroids may selectively regulate hippocampal
5-HT1A
receptors at the level of
5-HT1A
receptor mRNA expression.
...
PMID:Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression. 844 Oct 16
Complex interactions exist between the hypothalamic-pituitary-adrenal (HPA) axis and the serotonergic system, and it has been suggested that these interactions may be fundamental to the pathophysiology and treatment of depressive illnesses. It has previously been found that chronic administration of corticosterone leads to adrenal suppression and an attenuation of somatodendritic
5-HT1A
receptor function. Adrenalectomy (
ADX
) has been shown to cause an increase in postsynaptic
5-HT1A
receptor numbers and possibly function. However, other reports have suggested that
ADX
does not alter somatodendritic
5-HT1A
receptor mRNA or binding, though little is known of the effect of
ADX
on the function of somatodendritic
5-HT1A
receptors. This study investigated the effect of markedly reducing corticosterone levels by
ADX
on 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)-induced hypothermia in mice, an in vivo model of somatodendritic
5-HT1A
receptor function. The degree of 8-OH-DPAT-induced hypothermia did not differ between control, sham, and
ADX
animals 14 days post operatively. Although repeated administration of corticosterone attenuates somatodendritic
5-HT1A
receptor function, these data demonstrate that lowering of corticosteroid levels by
ADX
have no effect. This suggests that the effects of repeated corticosterone administration is not mediated by a secondary adrenal suppression. The difference in the effects of
ADX
on somatodendritic as opposed to postsynaptic
5-HT1A
receptors may reflect the differential expression of corticosteroid receptor subtypes at postsynaptic and somatodendritic sites.
...
PMID:Effects of adrenalectomy on 8-OH-DPAT induced hypothermia in mice. 1010 85
Alterations of the hypothalamic-pituitary-adrenal (HPA) axis function characterized by a decreased negative feedback capacity are often associated with affective disorders and are corrected by treatment with antidepressant drugs. To gain a better understanding of the effects of the antidepressant drug fluoxetine, a specific serotonin (5-HT) reuptake inhibitor, on central corticosteroid receptors, the effects of short-term activation of serotonin transmission on central corticosteroid receptor expression were analysed in adrenalectomized (
ADX
) rats either supplemented or not with corticosterone. Serotonin transmission was stimulated either by a single injection of the 5-HT precursor, 5-hydroxy-L-tryptophan (5-HTP), or by a 2-day treatment with fluoxetine. In
ADX
rats, administration of 5-HTP decreased hippocampal mineralocorticoid (MR) and glucocorticoid (GR) receptor numbers 24 h later, while their respective mRNAs were unchanged and these effects of 5-HTP were mediated by 5-HT2 receptors. In the hypothalamus, GR mRNAs and binding sites decreased 3 h and 24 h after 5-HTP, respectively. By contrast, fluoxetine treatment increased hippocampal MR and GR mRNAs and MR binding sites while GR number remained unchanged. In
ADX
rats supplemented with corticosterone, 5-HTP and fluoxetine treatment had the same effects on corticosteroid receptors compared to those observed in non supplemented
ADX
rats: 5-HTP decreased hippocampal MR and GR and hypothalamic GR while fluoxetine treatment increased hippocampal MR. These results show that short-term stimulation of 5-HT transmission by 5-HTP decreases hippocampal and hypothalamic corticosteroid receptor numbers through a corticosterone-independent mechanism. It is hypothesized that the delayed maximal increase in extracellular 5-HT contents after fluoxetine treatment, due to negative feedback regulations induced by the activation of
5-HT1A
and 5-HT1B autoreceptors, is not the primary cause for the delayed normalization of corticosteroid receptor numbers that regulates the HPA axis functioning.
...
PMID:Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-L-tryptophan or fluoxetine. 1092 85
1
2
Next >>